Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke

This study has been completed.
Sponsor:
Collaborator:
Zhejiang Otsuka Pharmaceutical Co., Ltd.
Information provided by:
Otsuka Beijing Research Institute
ClinicalTrials.gov Identifier:
NCT00202020
First received: September 12, 2005
Last updated: March 15, 2006
Last verified: March 2006